Dalix Therapeutics
Valley Stream, US · Founded 2015 · Delaware corporation
Founders & leadership
DL
DAVID LUBINExecutive
RA
RAN ALONExecutive
YD
YORAM DRUCKERExecutive
LS
LEONARD STERNHERMNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$750K disclosed across 1 round · 2016
▶$750KraisedFeb 2016 · 3 investors · BiotechnologyRule 506(b)
▶$750KraisedFeb 2016 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- DAVID LUBINExecutive Officer
- RAN ALONExecutive Officer
- LEONARD STERNHERMExecutive Officer, Director, Promoter
- YORAM DRUCKERExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $750K
- Proceeds to insiders
- $250K
- First sale
- Jan 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Dalix Therapeutics raised?
- Dalix Therapeutics has disclosed $750K raised across 1 round.
- Where is Dalix Therapeutics headquartered?
- Dalix Therapeutics is headquartered in Valley Stream, US.